In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breath Therapeutics Holding BV

Division of Zambon Co. SPA
www.breath-therapeutics.com

Latest From Breath Therapeutics Holding BV

Deal Watch: Celgene Reworks Alliance With Jounce, Gaining Global Rights To Macrophage-Targeting Candidate

Revised agreement of 2016 collaboration returns all vopratelimab rights to Jounce. Gilead fortifies antiviral pipeline in deals with Novartis, Durect.

Deals M & A

Breath Therapeutics Snapped Up Post Series A By Specialty Company Zambon

Italy’s privately held Zambon could pay up to 500m to bulk up its respiratory products pipeline, producing a nice return for Breath Therapeutics’ syndicate of European investors.

 

M & A Respiratory

Value-Added Respiratory Round-Up: Cipla Teams With Pulmatrix For Itraconazole

Cipla has struck a deal for dry-powder itraconazole and has also launched a fine-particle beclometasone/formoterol inhaler in India.
Value-Added Medicines Respiratory

Appointments: New CEO For Silence Therapeutics, Medical Heads Join Merck, Breath Therapeutics, Immusoft

David Solomon’s entrance as Silence Therapeutics’ new CEO leads this week’s new hires. While Ireland-based Malin shakes up its board of directors, other execs join Merck, Apeiron Biologics, Vectura, Roivant, OncoSec, Breath Therapeutics, Immusoft and M3 Biotechnology.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Zambon Co. SPA
  • Senior Management
  • Jens Stegemann, PhD, CEO
    Anne Burger, CFO
    Gerhard Boerner, PhD, CSO
    Oliver Denk, PhD, COO
    Peter Shaddy, Chief Commercial Officer
  • Contact Info
  • Breath Therapeutics Holding BV
    Aldringenstrasse 4
    Munich, 80639
    Germany
UsernamePublicRestriction

Register